Novo Nordisk to use renewable energy at all global production plants by 2020

Danish pharmaceutical firm Novo Nordisk has announced a new ambition to run all its global production sites only on electricity generated from renewable sources by 2020. Once implemented, there will be no CO2 emissions from the electricity used at the company's plants.
 
“Setting an absolute target of zero CO2 emissions from electricity at all our global production sites in just five years is ambitious, as our production is growing to meet the increasing global demand for our diabetes products,” said Henrik Wulff, executive vice president and head of Novo Nordisk Product Supply.
 
At present, the company's production sites in Denmark, Brazil and Japan use electricity from renewable sources. Last month Novo Nordisk’s production site Tianjin in China signed an agreement on purchasing electricity from a windmill farm in Inner Mongolia. Other production sites in the US, France, Russia, Algeria and Iran will enter similar agreements in the coming years.
   
“In Denmark, we get our electricity from windmills and this will also be the case in China, but there is not a one-size-fits-all solution and we will identify the most efficient renewable electricity sources for our production facilities in the other countries. Switching to renewable electricity makes sense from both a climate and a cost perspective. As more companies invest in renewable electricity, the technology is likely to get even more efficient and less costly,” explained Henrik Wulff
 
Novo Nordisk has recently, together with some of world's most influential companies, joined the RE100, which is a collaborative initiative of global businesses committed to using 100 percent renewable electricity.